Trials / Completed
CompletedNCT00412789
Efficacy and Safety of Patupilone in Patients With Advanced Solid Tumors in Japan
A Phase IA, Open-label, Dose Escalation Study of Patupilone Administered Intravenously Every 3 Weeks in Adult Patients With Advanced Solid Tumors
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 15 (actual)
- Sponsor
- Novartis Pharmaceuticals · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
The study will evaluate the safety and efficacy of Patupilone in adult patients with advanced solid tumors.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Patupilone |
Timeline
- Start date
- 2006-08-01
- Primary completion
- 2008-01-01
- First posted
- 2006-12-18
- Last updated
- 2010-05-31
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT00412789. Inclusion in this directory is not an endorsement.